| SC 13D/A | 2014-04-02 | CELGENE CORP /DE/ | ACCELERON PHARMA INC | 3,511,866 | 11.3% | EDGAR |
| SC 13D/A | 2014-03-07 | CELGENE CORP /DE/ | Alliqua, Inc. | 2,508,711 | 20.8% | EDGAR |
| SC 13G/A | 2014-02-12 | CELGENE CORP /DE/ | TENGION INC | - | 10.0% | EDGAR |
| SC 13G/A | 2014-02-04 | BlackRock Inc. | CELGENE CORP /DE/ | 25,732,210 | 6.2% | EDGAR |
| SC 13D/A | 2014-01-30 | CELGENE CORP /DE/ | ACCELERON PHARMA INC | 3,511,866 | 11.3% | EDGAR |
| SC 13G | 2013-12-16 | CELGENE CORP /DE/ | OncoMed Pharmaceuticals Inc | 1,470,588 | 5.0% | EDGAR |
| SC 13D | 2013-11-27 | CELGENE CORP /DE/ | Alliqua, Inc. | 2,508,711 | 20.8% | EDGAR |
| SC 13D | 2013-10-03 | CELGENE CORP /DE/ | ACCELERON PHARMA INC | 3,211,866 | 11.4% | EDGAR |
| SC 13G/A | 2013-02-08 | BlackRock Inc. | CELGENE CORP /DE/ | 24,465,445 | 5.8% | EDGAR |
| SC 13G/A | 2013-01-31 | JANUS CAPITAL MANAGEMENT LLC | CELGENE CORP /DE/ | 18,867,506 | 4.5% | EDGAR |
| SC 13G | 2012-10-09 | CELGENE CORP /DE/ | TENGION INC | - | 10.0% | EDGAR |
| SC 13G/A | 2012-02-14 | JANUS CAPITAL MANAGEMENT LLC | CELGENE CORP /DE/ | 29,036,430 | 6.5% | EDGAR |
| SC 13G | 2012-02-09 | BlackRock Inc. | CELGENE CORP /DE/ | 23,658,095 | 5.3% | EDGAR |
| SC 13G/A | 2011-03-09 | BlackRock Inc. | CELGENE CORP /DE/ | 23,413,681 | 5.0% | EDGAR |
| SC 13G/A | 2011-02-14 | JANUS CAPITAL MANAGEMENT LLC | CELGENE CORP /DE/ | 40,118,643 | 8.5% | EDGAR |
| SC 13G/A | 2011-02-03 | BlackRock Inc. | CELGENE CORP /DE/ | 23,547,336 | 5.0% | EDGAR |
| SC 13D/A | 2010-10-19 | CELGENE CORP /DE/ | Abraxis BioScience, Inc. | 40,735,300 | 100.0% | EDGAR |
| SC 13D | 2010-07-08 | CELGENE CORP /DE/ | Abraxis BioScience, Inc. | 33,215,612 | 82.1% | EDGAR |
| SC 13G/A | 2010-02-16 | FMR LLC | CELGENE CORP /DE/ | 9,816,062 | 2.1% | EDGAR |
| SC 13G/A | 2010-02-16 | JANUS CAPITAL MANAGEMENT LLC | CELGENE CORP /DE/ | 48,229,731 | 10.5% | EDGAR |